Cite
Iridium oxide (IV) nanoparticle-based lateral flow immunoassay
MLA
Alfredo de la Escosura-Muñiz, et al. Iridium Oxide (IV) Nanoparticle-Based Lateral Flow Immunoassay. Jan. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2a5d1a760cb2bd06bce033c6296b09a1&authtype=sso&custid=ns315887.
APA
Alfredo de la Escosura-Muñiz, Daniel Quesada-González, Tribidasari A. Ivandini, Amadeo Sena-Torralba, Arben Merkoçi, & Wiyogo Prio Wicaksono. (2019). Iridium oxide (IV) nanoparticle-based lateral flow immunoassay.
Chicago
Alfredo de la Escosura-Muñiz, Daniel Quesada-González, Tribidasari A. Ivandini, Amadeo Sena-Torralba, Arben Merkoçi, and Wiyogo Prio Wicaksono. 2019. “Iridium Oxide (IV) Nanoparticle-Based Lateral Flow Immunoassay,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2a5d1a760cb2bd06bce033c6296b09a1&authtype=sso&custid=ns315887.